Transplantation of high-purity mesenchymal stem cells (REC-01)

2 trials

Sponsors

Okahashi Masaaki, Taketani Takeshi

Conditions

severe hypophosphatasia

Phase 2

Phase I / IIa clinical study (FIH study) to investigate the safety and efficacy of high-purity mesenchymal stem cell (REC-01) transplantation in pediatric patients with hypophosphatasia

Active, not recruitingJPRN-jRCT2063210019

Taketani Takeshisevere hypophosphatasia

Start: 2021-06-23Target: 3Updated: 2026-06-29

Phase I / IIa clinical study (FIH study) to investigate the safety and efficacy of high-purity mesenchymal stem cell (REC-01) transplantation in pediatric patients with hypophosphatasia (REC-01-002)

Active, not recruitingJPRN-jRCT2053250167

Okahashi Masaakisevere hypophosphatasia

Start: 2025-12-16Target: 3Updated: 2026-06-29